ONCOLOGY

Your Patients Need Clinical Intelligence at 2 AM, Not a Generic Chatbot

MemberCare deploys 100 regimen-specific AI agents across 8 treatment modalities -- giving your patients 24/7 symptom triage that acts like your best oncology nurse.

See the Oncology AI Demo Explore AI Agents

100+ Oncology AI Agents

50+ Regimen Protocols

36 Clinical AI Protocols

The Gaps That Keep Oncology Leaders Up at Night

The Weekend Gap

Patients suffer between 5 PM Friday and 8 AM Monday with no clinical guidance. Symptoms escalate. ER visits happen. Outcomes worsen.

Generic Chatbots Fail

Competitors give the same response for mild nausea and febrile neutropenia. A FOLFOX patient on Day 10 with 100.8F fever needs an ER -- not "call your doctor."

Staff Burnout

After-hours call triage is exhausting. Nurses answer the same questions hundreds of times. The cognitive load is unsustainable.

Revenue Leakage

Care coordination happens daily but goes undocumented. CCM and RPM revenue is left on the table because there's no system to capture it.

Regimen-Specific Intelligence, Not Generic Advice

Every agent knows the specific drug regimen, its side effect profile, critical timelines, and emergency triggers.

24/7 Patient Symptom Triage

Patient-facing agents use warm, nurse-like language. Multi-turn assessment asks follow-up questions. Emergency-first responses for critical symptoms.

Composable Architecture

Each treatment protocol is backed by deep clinical intelligence that spans multiple specialties. When oncology care intersects with nutrition, pain management, or other domains, the platform coordinates seamlessly -- just like a real clinical team.

Prior Authorization AI

AI-generated PA letters with drug-specific clinical justification. Automated payer rule matching and denial appeal support.

Survivorship Care Planning

Post-treatment planning, long-term monitoring, and care gap closure.

Live AI Collaboration

The Intelligent Tumor Board

AI agents and clinicians review cancer cases together in real time. Staging, labs, drug interactions, nutrition, genomics — every specialist perspective, orchestrated in a single live session.

Session In Progress

6 Clinicians 8 AI Agents Real-Time

Case Brief — Auto-Generated

Diagnosis Stage IIIB NSCLC, EGFR+

Current Regimen Osimertinib 80mg QD

ECOG Status 1 — Ambulatory

Key Labs ANC 1.8, Cr 0.9, LFTs normal

Active AI Agents

Oncology

Lab Analyst

Pharmacy

Nutrition

Radiation

Prior Auth

Staging

Triage

Dr. Rivera

Patient progressed on osimertinib after 14 months. @Oncology what are the next-line options for EGFR+ NSCLC post-osimertinib?

Oncology Agent

Post-osimertinib options include platinum-based doublet (carboplatin + pemetrexed), amivantamab + lazertinib (MARIPOSA-2), or clinical trial enrollment. Recommending tissue re-biopsy to assess resistance mechanism (C797S, MET amp, SCLC transformation). @Lab Analyst please review recent molecular panel.

Lab Results Agent

Latest NGS panel shows T790M negative, MET amplification detected (copy number 8). MET-directed therapy (capmatinib or tepotinib) may be appropriate. ANC is adequate for combination therapy.

Dr. Chen

@Prior Auth what does payer coverage look like for capmatinib in this scenario?

Prior Auth Agent is analyzing payer formulary…

Auto Case Prep

AI agents compile diagnosis, staging, labs, treatment history, and performance status before the session begins.

@Mention Any Agent

Oncology, nutrition, pharmacy, radiology — ask any specialist AI agent by name during the live discussion.

Agent-to-Agent Consult

Agents autonomously consult peer specialists — the oncology agent can ask the lab agent to interpret results mid-conversation.

Recommendations & Export

Capture consensus recommendations, voting, and rationale — exported directly to the patient care plan.

See the Tumor Board in Action

Capture Revenue You're Missing Today

$235+ Per Patient Per Month CCM/RPM Revenue

$200K+ Per Physician Annually From Infusion Therapy

100% Protocol Compliance Documented & Billable

Calculate Your Oncology Revenue

Coverage Across 8 Treatment Modalities

AI agents trained on every major cancer treatment category — from first-line chemotherapy to emerging immunotherapies.

Chemotherapy

15+ regimen-specific agents covering frontline and salvage protocols

Immunotherapy

Checkpoint inhibitor monitoring with irAE-specific triage protocols

Chemo-IO Combos

Combined regimen agents that understand overlapping toxicities

CAR-T Cell Therapy

CRS and neurotoxicity monitoring with immediate escalation protocols

Targeted Therapy

Oral targeted agent monitoring with adherence and side effect tracking

Hormonal Therapy

Long-term endocrine therapy management and quality-of-life monitoring

Radiation Therapy

Site-specific radiation side effect management across 6 body regions

Chemoradiation

Concurrent therapy monitoring with combined toxicity awareness

How We Compare

Feature	Generic Chatbot Platforms	ePRO / Data Collection Tools	MemberCare
Response type	Generic chatbot	ePRO dashboard (passive)	Regimen-specific clinical intelligence
Response time	6-8 hours	N/A (data collection only)	Instant, 24/7
Clinical intelligence	Same response for all	No triage capability	Knows Day 10 fever = febrile neutropenia
Patient guidance	Generic advice	None (waits for clinician)	Action-first with immediate self-care
Clinical depth	None	None	Deep clinical training per regimen and drug class
Cross-specialty collaboration	None	None	Cross-specialty AI consultation across disciplines

“MemberCare’s AI agents caught a critical symptom flag at 2 AM that would have sent our patient to the ER. Instead, they got immediate guidance and called us in the morning. That’s the difference.”

Practice Administrator, Multi-Site Oncology Network

100% Protocol Compliance

0 Missed Checkpoints

50+ Patients Managed

Frequently Asked Questions

Common questions about AI-powered oncology symptom management and protocol intelligence.

AI-powered oncology symptom management uses regimen-specific clinical AI agents to triage cancer symptoms 24/7. Unlike generic chatbots, these agents are trained on specific protocols like FOLFOX, AC-T, and immunotherapy regimens, so they understand the expected side effects, timing, and severity thresholds for each treatment. For example, a FOLFOX agent knows that a fever on Day 10 may indicate febrile neutropenia — an oncologic emergency — while a Day 2 low-grade fever may be a normal reaction.

MemberCare deploys 100 regimen-specific AI agents across 8 treatment modalities including chemotherapy, immunotherapy, CAR-T cell therapy, targeted therapy, hormonal therapy, and radiation. Each agent is trained on drug-class knowledge bases and regimen-specific protocols, enabling it to ask the right follow-up questions, provide immediate self-care guidance, and escalate true emergencies — all in a warm, nurse-like tone.

MemberCare supports 50+ oncology treatment protocols including FOLFOX, FOLFIRI, FOLFIRINOX, AC-T, Carboplatin-Paclitaxel, R-CHOP, BEP, ABVD, Temozolomide, and Capecitabine for chemotherapy; Pembrolizumab, Nivolumab, Atezolizumab, and Durvalumab for immunotherapy; Yescarta, Kymriah, and Breyanzi for CAR-T; plus targeted therapy, hormonal therapy, radiation therapy, and chemoradiation protocols.

Yes. MemberCare includes a Prior Authorization Expert AI agent that understands drug-specific PA requirements, payer rules, and denial appeal processes. It can generate PA letters automatically, track authorization status, and manage the end-to-end prior auth workflow — reducing staff time spent on phone holds and paperwork.

Oncology RPM with AI symptom triage catches concerning symptoms before they escalate to emergencies. When a patient reports symptoms between visits, the AI agent triages based on the specific regimen they are on, provides immediate self-care actions, and escalates to the care team when needed. This means issues like dehydration, uncontrolled nausea, or early signs of infection are addressed proactively rather than in the ER.

Most platforms offer generic chatbots or passive ePRO data collection. MemberCare delivers regimen-specific clinical intelligence — each AI agent is trained on specific drug protocols and knows the clinical significance of symptoms in context. It responds instantly 24/7, provides action-first guidance (not just "call your doctor"), and uses Agent-to-Agent consultation to coordinate across specialties like nutrition, lab results, and pain management.

Ready to Transform Your Oncology Practice?

See how 100 AI agents can extend your care team's reach -- 24 hours a day, 7 days a week.

See the Oncology AI Demo VBC & ACO Solutions

Part of a value-based contract? These oncology capabilities drive quality scores, reduce avoidable utilization, and protect shared savings.

Or call us: 214.226.5319